Protein kinase screening using the Upstate KinaseProfiler selectivity profiling service helps researchers evaluate potential leads and guide medicinal chemistry to optimize the most promising compounds and avoid the development of non-specific lead candidates. The panel of kinases assembled for the service is expansive and disease-relevant, and is under continuous improvement and expansion. The direct, radiometric assay format used in the service assures robust and reliable data that is both reproducible and validated.